Technology in Diabetes
Technology of last generation for the control and monitoring of diabetes, which allow patients to a life more full and quiet.
When a patient is diagnosed with diabetes, it is natural to feel overwhelmed, scared, unsure and confused, without having very clear of how will be your life from now on. However, both for type 1 diabetes, such as type 2, there are innovative solutions that will allow you to continue to live your life with great freedom and safely.
Insulin pump
Diabetes patients know that the continuous monitoring and the supply of medication exact at all times, are key aspects to control your condition. Our therapies provide a better control of your diabetes and improve their quality of life.
MiniMed it is a microinfusor that automatically adjusts insulin levels of the patient every 5 minutes, using glucose readings in real-time, thus preventing the high and low levels of glucose in the blood.
Guardian Connect
Continuous monitoring of Glucose
It is a system of continuous monitoring of glucose, which keeps track of the levels of glucose, 24 hours a day, 7 days a week, through a small sensor that is inserted under the skin, either in the abdomen or in the arm by an inserter automatic. Guardian Connect can be used with or without a insulin pump.
With the Guardian Connect system can display the levels and trends of glucose, directly on your mobile device. You will receive different types of alerts, including predictive with up to 60 minutes in advance.
Benefits
Discover more in less time
During the evaluation, it is possible to generate a rreport patient-tailored, linked to their behaviors in life style.
To identify the priorities of the patient
When conducting an assessment for 6 or 7 days, whereas peaks and troughs of glucose, activities, and meals for the patient, you will be able to identify the moments with greater fluctuations.
Fast and easy process
To start the evaluation process with Guardian Connect is a quick and easy. The process of insertion of the sensor takes a few minutes and the patient only needs to be trained in how to record the activities in a log book.
Diagnostic test and Prognostic
Is a clinical trial of biomarkers, used to measure the risk of developing diabetic nephropathy (kidney disease) in patients with diabetes.
With this technology identifies the risk of Diabetic Kidney Disease (DKD) at the time of taking the test, in addition to quantify the risk of developing this condition in the future, with up to 4 years in advance.
Benefits
Identifying patients at risk of developing chronic kidney disease in the next 4 years
Implement preventive measures before damage occurs renal
Allows you to customize the treatment of the patient, according to their present condition and future